Evidence map›Paper›PMID 42523222›Full record

ArticlebioRxiv : the preprint server for biology2026

Maternal vaccination timing shapes the composition and maturation of antibody clonotypes transferred to the newborn.

Aisha Yesbolatova, Lowrey Peyton, Nicholas C Curtis, Tae Kim, Jinyoung Yoon, Hunter J Melton, Noor M Taher, Tae-Geun Yu, Brian H Kim, Dhvanir N Kansara and 11 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Aisha YesbolatovaThayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.
Lowrey PeytonThayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.
Nicholas C CurtisThayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.
Tae KimHIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.
Jinyoung YoonThayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.
Hunter J MeltonDepartment of Biomedical Data Science and Dartmouth Cancer Center, Geisel School of Medicine, Dartmouth, Hanover, NH 03755, USA.
Noor M TaherInstitute for Biomolecular Targeting (bioMT), Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA.
Tae-Geun YuThayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.
Brian H KimThayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.
Dhvanir N KansaraDepartment of Microbiology and Immunology, Geisel School of Medicine, Dartmouth College, Hanover, NH 03755, USA.
Matthew R StonerThayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.
Ellison OberHIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.
Emma VarellaHIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.
Pieter PannusEuropean Plotkin Institute for Vaccinology, Université libre de Bruxelles, Brussels, Belgium.
Larissa DeBrabandereCentre for the Evaluation of Vaccination, Vaccine & Infectious Diseases Institute, University of Antwerp, Belgium.
Kirsten MaertensCentre for the Evaluation of Vaccination, Vaccine & Infectious Diseases Institute, University of Antwerp, Belgium.
Kenneth B HoehnDepartment of Biomedical Data Science and Dartmouth Cancer Center, Geisel School of Medicine, Dartmouth, Hanover, NH 03755, USA.
Mark ConnorsHIV-Specific Immunity Section of the Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.
Arnaud MarchantCentre for the Evaluation of Vaccination, Vaccine & Infectious Diseases Institute, University of Antwerp, Belgium.
Margaret E AckermanThayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.
Jiwon LeeThayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA.

Funding

Understanding the role of RNA-binding protein mutations in cancerP20GM113132 · NIGMS · DARTMOUTH COLLEGE · PI MIERKE, DALE F · 2016 to 2025
$25.9M
Transferred ImmunityU19AI145825 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI MARCHANT, ARNAUD · 2021 to 2025
$16.0M
Training Program for Quantitative Population Sciences in CancerT32CA134286 · NCI · DARTMOUTH COLLEGE · PI KARAGAS, MARGARET RITA, TOSTESON, TOR D · 2020 to 2024
$1.5M
NCI NIH HHS T32 CA134286NIAID NIH HHS U19 AI145825NIGMS NIH HHS P20 GM113132
6 · The paper itself

Abstract

Newborns rely on maternally transferred antibodies for immune protection, acquired across the placenta and through breast milk. Despite this importance, how closely the inherited antibody repertoire resembles the mother's has not been examined at the clonotypic level. We combined BCR-Seq with proteomic Ig-Seq to track SARS-CoV-2-specific antibody clonotypes across maternal blood, cord blood, and breast milk from six mRNA-immunized pregnant individuals. Vaccination earlier in gestation generated more diverse peak IgG repertoires but greater contraction before delivery, yielding fewer transferred clonotypes. Vaccination later in gestation produced more restricted peak repertoires, but more clonotypes persisted to delivery and transferred to cord. Infant cord was enriched for persistent, highly somatically mutated, and intraclonally diverse IgG clonotypes, consistent with preferential transfer of affinity-matured antibodies. In contrast, breast milk IgA repertoires were largely distinct from systemic repertoires and underwent substantial remodeling despite stable antigen titers. These findings define molecular determinants of passive immunity shaped by vaccination timing relevant to optimizing maternal immunization.

Identifiers

PMID42523222
PMCPMC13404753

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.